Estee Lauder Companies Inc (EL) stock price, news and key stats

Price

Last trade as of Sep 16, 2026. Delayed data; not a live quote.

Previous close

$96.22

Open

$96.49

Day range

$94.48 – $96.69

Volume

93.2K

52-week range

$66.22 – $121.64

Market cap

$34.6B

Forward P/E

24.4

Dividend yield

145.00%

Beta

1.27

Avg. volume

3.1M

Analyst target

$107.04

Next earnings

Nov 2, 2026

About Estee Lauder Companies Inc

Latest EL news

• How beauty giant Estee Lauder’s top technologist is betting on ‘AI everywhere’ to fuel its turnaround
  Fortune · Sep 9, 2026

  Estee Lauder has announced a strategic shift in its leadership as Brian Franz, the company's top technologist, assumes an expanded role in the C-suite. This move comes at a critical time for the beauty giant, which is seeking to leverage artificial intelligence (AI) to drive its turnaround efforts. Franz, who oversees data, technology, and analytics, is expected to implement AI-driven initiatives across the company’s brands, including M.A.C and Clinique, aiming to enhance customer engagement and streamline operations. The beauty industry has increasingly turned to technology to adapt to changing consumer preferences, and Estee Lauder's focus on "AI everywhere" reflects a broader trend among retailers to integrate advanced analytics and personalized marketing strategies. Analysts suggest that this pivot could help the company better compete in a crowded market, particularly as consumers demand more tailored experiences. As Estee Lauder invests in AI capabilities, the potential for improved operational efficiency and customer insights could lead to a stronger market position and ultimately drive sales growth. Market implications are significant, as Estee Lauder's commitment to technology may attract investor interest, particularly in a sector where innovation is key to maintaining relevance. If successful, this strategy could not only bolster the company's financial performance but also set a precedent for other beauty brands looking to harness technology in their own operations. The move signals a proactive approach to navigating the challenges of a post-pandemic retail landscape, where digital engagement is paramount.

• What Does Canada’s Tariff War Mean For The Beauty Influencer Economy?
  Macro Watch · Sep 8, 2026

  Canada's recent imposition of tariffs on U.S. beauty goods is set to significantly impact the mid-market beauty influencer economy. Effective September 8, these tariffs, which match the U.S. tariffs dollar for dollar, are expected to squeeze both brands and creators who rely on affordable beauty products to engage their audiences. As the cost of imported goods rises, mid-tier brands may be forced to increase prices, potentially alienating their consumer base and diminishing the purchasing power of influencers' followers. The tariff escalation comes amid ongoing trade tensions between the U.S. and Canada, which could lead to a ripple effect in the beauty industry. Influencers who have built their platforms around promoting mid-range products may need to pivot their strategies, either by shifting focus to domestic brands or by adjusting their content to reflect the new pricing landscape. This shift could alter brand partnerships and sponsorship deals, as companies reassess their marketing budgets in light of increased costs. Market implications are significant; as consumer prices rise, demand for beauty products may decline, particularly in the mid-market segment. Influencers may find it challenging to maintain engagement and sales conversions, leading to a potential revaluation of their worth in brand collaborations. Overall, the tariff war not only threatens the profitability of beauty brands but also poses a challenge for influencers who depend on these brands for their income.

• EssilorLuxottica overhauls management after rift with founder’s son
  FT Companies · Sep 7, 2026

  EssilorLuxottica has announced a significant management overhaul following a governance rift involving Leonardo Maria Del Vecchio, the son of the company's late founder. Del Vecchio is stepping down from his management roles amid concerns over the strategic direction of the eyewear giant, which has seen its shares plummet by 44% year-to-date, despite reporting strong earnings and initiating a share buyback program. This leadership change reflects growing tensions regarding CEO Francesco Milleri's mandate and the need for a revised strategy to restore investor confidence. The departure of Del Vecchio, who has been vocal about the company's need for a new strategic approach, raises questions about the future direction of EssilorLuxottica. The company's stock has suffered significantly, losing over 50% of its value in recent months, prompting calls for a reassessment of its operational and financial strategies. Analysts suggest that the management shake-up could lead to a more agile response to market challenges, potentially stabilizing the stock and improving investor sentiment in the long term. As the company navigates this transition, stakeholders will be closely monitoring how these changes impact its competitive positioning in the eyewear market.

• S&P 500 Futures Climb in Premarket Trading; Moderna, Estee Lauder Lead
  Futures Trading · Aug 19, 2026

  S&P 500 futures rose in premarket trading, buoyed by significant gains in shares of Moderna and Estee Lauder. Moderna's stock surged by 61.2% following positive developments regarding its COVID-19 vaccine, which has sparked renewed investor interest in biotech stocks. Estee Lauder also saw a notable increase of 8.3%, likely driven by strong quarterly earnings that exceeded analyst expectations. The upward movement in futures suggests a positive opening for the broader market, reflecting investor optimism amid these corporate earnings reports. The gains in Moderna and Estee Lauder may indicate a broader trend of recovery in sectors hit hard by the pandemic, particularly in healthcare and consumer goods. As investors assess the implications of these developments, market analysts will be closely watching how these stocks perform in the context of overall economic recovery and consumer sentiment.

• Beiersdorf Aktiengesellschaft reports Q1 results; reaffirms FY26 outlook
  Seeking Alpha · Apr 21, 2026

  Beiersdorf Aktiengesellschaft reported Q1 2025 group sales of €2.69 billion, marginally ahead of consensus estimates, and reaffirmed its full-year 2026 outlook. The result marks the first quarterly earnings release among European large-cap health and personal care companies, serving as an early read on consumer demand resilience in the sector. Sales growth was driven by strong performance in the Derma division — anchored by Eucerin and Aquaphor — which benefited from prescription channel strength and dermatology-led innovation, while the Luxury segment (including La Prairie) continued to face headwinds amid softening demand in key Asian markets and elevated inventory levels at distributors. Regionally, Beiersdorf saw solid growth in Europe and Asia-Pacific, offsetting a slight decline in the Americas — attributed to category-specific softness in prestige skincare and competitive promotional intensity. Gross margin held steady year-on-year, though operating margin dipped modestly due to higher marketing spend supporting new product launches and digital transformation initiatives. The company emphasized continued investment in R&D and supply chain resilience, particularly for active pharmaceutical ingredient (API)-enabled dermocosmetics, as part of its long-term strategy to shift toward science-led, medical-adjacent personal care. Market implications are nuanced: Beiersdorf’s relative outperformance in dermo-pharma adjacent categories reinforces investor interest in defensible, clinically substantiated consumer health segments — a theme increasingly diverging from broad-based consumer staples. Its reaffirmation of FY26 guidance signals confidence in underlying pricing power and portfolio rebalancing, though sustained luxury weakness may pressure peer valuations in the premium beauty space. Equity investors will monitor upcoming Q2 reports from L’Oréal and Estée Lauder for confirmation of regional divergence and category-level inflection.

Earnings history

Index membership

• S&P 500 · Consumer Staples

Related Consumer Staples stocks

• ADMArcher Daniels Midland
• BF-BBrown–Forman
• BGBunge Global
• CASYCasey's
• CHDChurch & Dwight
• CLColgate-Palmolive
• CLXClorox
• COSTCostco